>

MEETINGS / EVENTS

RSS

May 05 - 07 2014, 12:00 AM - 12:00 AM

2014 ASA Legislative Conference

>

FDA MEDWATCH ALERTS

April 18, 2014

Propofol Injectable Emulsion, USP by Hospira: Recall - Visible Particulates

Summary:

Propofol Injectable Emulsion USP by Hospira Recall Visible Particulates

April 18, 2014

FDA MedWatch - ARKON Anesthesia Delivery System with Version 2.0 Software by Spacelabs Healthcare: Class I Recall

Summary:

FDA MedWatch Class I Recall 4 18 14

March 28, 2014

FDA Update on the Shortage of Normal Saline

Summary:

FDA Update on the Shortage of Normal Saline

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Anesthesiology Continuing Education (ACE) Program

SKU: 30702-14CE

... Read more »

Single Copies, Member Price: $360

ASA Congratulates Member Rafael Miguel, M.D. on his appointment to the FDA’s Anesthetic and Analgesic Drug Products Advisory Committee

Friday, October 25, 2013

Rafael Miguel, M.D. was recently appointed to the U.S. Food and Drug Administration's (FDA) Anesthetic and Analgesic Drug Products Advisory Committee. This 13 member FDA Advisory Committee is charged with reviewing and evaluating data regarding the safety and effectiveness of drugs used in anesthesiology and surgery, and formulating recommendations to the commissioner of the FDA.

Dr. Miguel specializes in pain medicine and currently has a practice affiliated with the University of South Florida (USF) with clinics in Tampa and Sarasota in Florida. He has served as the president of the Florida Society of Anesthesiologists, chairman of the USF Department of Anesthesiology, and as vice-chair of the Florida Board of Medicine. Dr. Miguel attended medical school at the University of Cadiz in Cadiz Spain and completed his residency in anesthesiology at Tulane University.

ASA congratulates Dr. Miguel on his appointment.

Learn more about the FDA's Anesthetic and Analgesic Drug Products Advisory Committee.

« Back to Washington Alerts